Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia

Australian and New Zealand Journal of Public Health

Volumn 37, Issue 2, 2013, Pages 132-138

  Hollingworth, Samantha A ^a   Symons, Martyn ^b   Khatun, Mohsina ^a   Loveday, Bill ^b   Ballantyne, Sue ^b   Hall, Wayne D ^a   Najman, Jake M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

Analgesics; Databases; Opioids; Oxycodone; Prescribing

Indexed keywords

NARCOTIC ANALGESIC AGENT;

AUSTRALIA; CLINICAL PRACTICE; DRUG UTILIZATION; FACTUAL DATABASE; FINANCIAL MANAGEMENT; HUMAN; PHARMACY; PRESCRIPTION; STATISTICS AND NUMERICAL DATA; TRENDS; ARTICLE; STATISTICS;

ANALGESICS, OPIOID; AUSTRALIA; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FINANCING, GOVERNMENT; HUMANS; PHARMACEUTICAL SERVICES; PHARMACIES; PRACTICE PATTERNS, PHYSICIANS'; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84875972947     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/1753-6405.12030     Document Type: Article

References (38)

1. Lintzeris N. The new wave of opioid dependence. Of Subst. 2009;7(3):10-11.
2. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81(2):103-7.
3. Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195(5):280-4.
4. National Drug and Alcohol Research Centre. Opioid Overdose Deaths in Australia 2004 Edition. NIDIP Bulletin. Sydney (AUST): University of New South Wales, NDARC; 2005.
5. Graham NA, Gold MS, Goldberger BA. Prescription opioids and overdose deaths. JAMA. 2009;301(17):1766. author reply 67-8.
6. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in Medical Use and Abuse of Opioid Analgesics. JAMA. 2000;283(13):1710-14.
7. Manchikanti L, Singh A. Therapeutic Opioids: A Ten-Year Perspective on the Complexities and Complications of the Escalating Use, Abuse, and Nonmedical Use of Opioids. Pain Physician. 2008(11):S63-S88.
8. Misono AS, Cutrona SL, Choudhry NK, Fischer MA, Stedman MR, Liberman JN, et al. Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care. 2010;16(12 Suppl HIT):SP82-92.
9. Bell Jr. Australian trends in opioid prescribing for chronic non-cancer pain, 1986-1996. Med J Aust. 1997;167:26-9.
10. Degenhardt L, Black E, Breen C, Bruno R, Kinner S, Roxburgh A, et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev. 2006;25(5):403-12.
11. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69:215-32.
12. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain [Cochrane Review]. In: Cochrane Database of Systematic Reviews. Issue 1, 2010. Chichester (UK): John Wiley & Sons; 2010.
13. Access Economics. The High Price of Pain: The Economic Impact of Persistent Pain in Australia. Sydney (AUST): MBF Foundation, University of Sydney, Pain Management Research Institute; 2007.
14. Australian Institute of Health and Welfare. Australian GP Statistics and Classification Centre. Prevalence and Management of Chronic Pain v [abstract]. Proceedings of the 8th Beach Program; 2005 April to 2006 March. Sydney (AUST): University of Sydney, Family Medicine Research Centre; 2008.
15. Buykx P, Loxley W, Dietze P, Ritter A. Medications used in overdose and how they are acquired - an investigation of cases attending an inner Melbourne emergency department. Aust N Z J Public Health. 2010;34(4):401-4.
16. Pharmacy Guild of Australia. Electronic Recording and Reporting of Controlled Drugs. Consultation Paper [Internet]. Canberra (AUST): Commonwealth Department of Health and Ageing; 2012 [cited 2012 Apr 6]. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/C8808B8122C D0FA7CA257830007C253C/$File/FINAL%20ERRCD%20Consultation%20 paper%20-%208%20March%202011.pdf
17. McIlwraith F, Hickey S, Alati R. Queensland Drug Trends 2010. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 63. Sydney (AUST): University of New South Wales, National Drug and Alcohol Research Centre; 2011.
18. Department of Health and Ageing. Australian Statistics on Medicines 2009. Canberra (AUST): Commonwealth of Australia; 2009.
19. ComLaw. Poisons Standard 2010 [Internet]. Canberra (AUST): Commonwealth of Australia; 2010 [cited 2012 Apr 6]. Available from: http://www.comlaw.gov. au/Details/F2010L02386
20. World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology. Geneva (CHE): WHO; 2008.
21. Australian Bureau of Statistics. 3201.0 - Population by Age and Sex, Australian States and Territories. Canberra (AUST): ABS; 2007.
22. Harrison CM, Charles J, Henderson J, Britt H. Opioid prescribing in Australian general practice. Med J Aust. 2012;196(6):380-1.
23. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J. 2009;39(10):676-81.
24. Blyth FM, March LM, Brnabic AJ, Jorm LR, Williamson M, Cousins MJ. Chronic pain in Australia: a prevalence study. Pain. 2001;89(2-3):127-34.
25. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69(3):215-32.
26. The Royal Australasian College of Physicians. Prescription Opioid Policy: Improving Management of Chronic Non-malignant Pain and Prevention of Problems Associated with Prescription Opioid Use. Sydney (AUST): RACP; 2009.
27. American Academy of Pain Medicine and the American Pain Society. The Use of Opioids for the Treatment of Chronic Pain. Glenview (IL): AAPM &APS; 1996.
28. Passik SD. Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions. Mayo Clin Proc. 2009;84(7):593-601.
29. Bailey J, Barton P, Lezotte D, Lowenstein S, Dart R. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. Drug Alcohol Depend. 2006;84(2):182-7.
30. Cicero TJ, Inciardi JA, Surratt H. Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend. 2007;91(2-3):115-20.
31. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221-7.
32. Hall WD, Farrell MP. Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia. Med J Aust. 2011;195(5):248-9.
33. Nicholas R, Lee N, Roche A. Responding to Pharmaceutical Drug Misuse in Australia: A Matter of Balance. A Review of Literature Supporting the Development of Australia's National Pharmaceutical Drug Misuse Strategy. Adelaide (AUST): National Centre for Education and Training on Addiction andFlinders University; 2011.
34. Department of Health and Ageing. Pharmaceutical Benefits Scheme Collection of Under Copayment Data. Canberra (AUST): Commonwealth of Australia; 2012 [cited 2012 Apr 6]. Available from: http://www.health.gov.au/internet/main/ publishing.nsf/Content/pbs-under-copayment-data
35. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-90.
36. Fischer B, Rehm J. Deaths related to the use of prescription opioids. Can Med Assoc J. 2009;181(12):881-2.
37. Warner M, Li Hui Chen D, Makuc D. Increase in Fatal Poisonings Involving Opioid Analgesics in the United States, 1999-2006. Hyattsville (MD) National Center for Health Statistics Data Brief; 2009.
38. Savage S, Covington E, Heit H, Hunt J, Joranson D, Schnoll S. Definitions Related to the Use of Opioids for the Treatment of Pain. A Consensus Document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Glenview (IL): AAPM, APS and ASAM; 2001.